Learn More
Despite substantial contributions on the part of public, non-profit, and private sector organizations, the burden of cancer in the United States remains high. As public health organizations, particularly county, state, tribal, and territorial health departments, try to reduce the significant burden of cancer, they face additional issues that make it(More)
BACKGROUND Loteprednol etabonate is a site-active corticosteroid with efficacy and safety in treating ocular inflammation at the 0.5% concentration. Evidence from dose-response studies suggested that the 0.2% concentration might be effective in treating ocular allergy. OBJECTIVES The objective of this study was to evaluate the effects of 0.2% loteprednol(More)
PURPOSE To evaluate the efficacy and safety of loteprednol etabonate 0.5% as prophylactic treatment for the ocular signs and symptoms of seasonal allergic conjunctivitis. METHODS In this randomized, double-masked, placebo-controlled, parallel study, 293 adults with history of seasonal allergic conjunctivitis were treated with either loteprednol etabonate(More)
A technique to recognize and quantitate oncornaviruses using perforated pointed BEEM capsules has been developed in our laboratory. Virus samples that presented problems in counting, or those which could not be evaluated at all by negative staining, could be clearly defined and counted using the thin-sectioning BEEM capsule technique. Perforation of the(More)
CONTEXT Increasing the adoption and implementation of evidence-based policies and practices is a key strategy for improving public health. Although there is widespread agreement about the importance of implementing evidence-based public health policies and practices, there are gaps between what has been shown to be effective and what is implemented at the(More)
  • 1